Kirk Perry was only 70 days into becoming the interim CEO of Kenvue when he was blindsided by our current administration. According to the Wall Street Journal, Mr. Perry met with Robert F. Kennedy Jr. about some studies that linked Kenvue’s Tylenol to autism. Perry felt the meetings were moving in the right direction. Then, ...

The post Another Tylenol Scare appeared first on Unconventional Business Network.